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Abstract
Epstein-Barr virus (EBV) encoded transcription factor Zta (BZLF1, ZEBRA, EB1) is the prototype of a class of transcription
factor (including C/EBPalpha) that interact with CpG-containing DNA response elements in a methylation-dependent
manner. The EBV genome undergoes a biphasic methylation cycle; it is extensively methylated during viral latency but is
reset to an unmethylated state following viral lytic replication. Zta is expressed transiently following infection and again
during the switch between latency and lytic replication. The requirement for CpG-methylation at critical Zta response
elements (ZREs) has been proposed to regulate EBV replication, specifically it could aid the activation of viral lytic gene
expression from silenced promoters on the methylated genome during latency in addition to preventing full lytic
reactivation from the non-methylated EBV genome immediately following infection. We developed a computational
approach to predict the location of ZREs which we experimentally assessed using in vitro and in vivo DNA association assays.
A remarkably different binding motif is apparent for the CpG and non-CpG ZREs. Computational prediction of the location
of these binding motifs in EBV revealed that the majority of lytic cycle genes have at least one and many have multiple
copies of methylation-dependent CpG ZREs within their promoters. This suggests that the abundance of Zta protein
coupled with the methylation status of the EBV genome act together to co-ordinate the expression of lytic cycle genes at
the majority of EBV promoters.
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Introduction
Infection of human B-lymphocytes by Epstein-Barr virus results
in the establishment of a latent state in which a highly restricted set
of viral genes are expressed [1]. This is accompanied by extensive
methylation of CpG motifs in non-expressed viral genes [2,3,4]. In
response to physiological stimuli, such as engagement of the B-cell
receptor, epigenetic silencing of the viral genome is overturned,
resulting in widespread activation of viral gene expression and lytic
replication [4,5]. The expression of a subset of host genes is also
altered during this period [6,7,8,9,10,11,12,13,14].
The switch between latency and the lytic cycle is orchestrated by
the viral gene BZLF1, which encodes the protein Zta (also known
as ZEBRA, BZLF1, EB1, or Z) [15,16,17]. Zta resembles the AP1
family of bZIP transcription factors but has a unique dimerisation
domain and does not form heterodimers with cellular bZIP
proteins [18]. Three classes of Zta DNA binding sites (Zta
response elements (ZREs)) have been defined for Zta [19]. Class I
ZREs include classical AP1-like recognition elements. However,
some Zta binding sites contain a CpG motif and Zta has the
unusual property of binding preferentially to these ZREs when
they are methylated [20,21], defining class II ZREs [19].
Remarkably, some CpG-containing ZREs are only recognized in
their methylated form (class III ZREs) [19,20,21,22,23,24,25].
Methylation of the viral genome occurs during latency and has
recently been shown to be required for EBV replication [3]. The
ability of Zta to bind to methylated ZREs suggests that Zta may
have a direct role in overriding the epigenetic silencing of the viral
genome to activate expression of viral genes required for lytic
replication.
The requirement for methylation at critical ZREs may also
contribute to the establishment of latency during the immortal-
ization of infected cells. The EBV genome is not methylated when
it enters cells but the genome gradually becomes methylated
during immortalization and the establishment of viral latency
[3,4]. Zta is transiently expressed during the early period
immediately after infection and is required for efficient immortal-
ization [3]. It is therefore essential that Zta should not activate the
full lytic replication cycle at this stage. A plausible hypothesis to
explain this is that expression of key lytic cycle genes are controlled
by class III ZREs that do not function in their unmethylated form.
We developed a computational approach to identify candidate
ZREs and applied it to a genome-wide analysis of the EBV
genome that revealed many novel target loci. The implications of
these data for the ability of EBV to evade epigenetic silencing of
the host viral genome is discussed.
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Results
Prediction of ZREs core sequences bound by Zta using
PROMO
In order to predict novel ZRE core sequences, we started by
searching three well-characterized Zta-responsive promoters from
the EBV genome (BZLF1 promoter (Zp) [26,27,28,29], BRLF1
promoter (Rp) [27,29,30] and BMRF1 promoter [31] using the
PROMO algorithm [33,34] and the position frequency matrix
(PFM) for Tranfac 8.3 Zta transcription factor entry T00923
[32,33]. These 3 promoters are known to contain eight previously
verified sites: in Zp (ZREIIIA and ZREIIIB); in Rp (ZRE1, ZRE2
and ZRE3) and in BMRF1 promoter (AP1, ZRE(244) and ZRE
(2107)) (Figure 1 and Table S1) however, the PROMO algorithm
only predicted one of these sites (RpZRE1) using the PFM
T00923. In addition, 6 novel sites where predicted (Table S2).The
ability of Zta to interact with each predicted site was assessed using
electrophoretic mobility shift assays (EMSA) (Figure 1, Table S2),
although three novel sites were identified, eight known sites were
missed and three false positives were predicted indicating that the
PFM used had a low sensitivity.
Application of a novel ZRE PFM to predict CpG
containing ZREs
A new PFM was generated using the core sequences of five CpG-
containing ZREs (denoted PFMCpG5) from the promoters described
above and the BRRF1 promoter [22] (Figure 2). The accuracy of the
PFM was evaluated by searching for ZREs in the well-characterized
viral promoters (Rp, Zp and BMRF1p). PFMCpG5 identified all 5
verified CpG containing sites and predicted two novel sites; one
located in Rp, centered on 2114, and one located in the BMRF1
promoter, centered on 2148. DNA binding experiments demon-
strate that Zta interacts with both sites in a methylation-dependent
manner, characteristic of class III ZREs (Figure 3), thus the new PFM
(ZRECpG5) has a high level of sensitivity. The PFMCpG5 was then
used to predict core ZREs in the complete EBV genome. Within the
EBV genome a total of 16 novel sequence variants of CpG ZREs
were predicted (A–P) (Figure 3). EMSAs were undertaken with each
of the novel ZRE core sequences (both non-methylated and
methylated) to evaluate Zta binding (Figure 3). All but two of the
predicted ZRE sequences bound in the methylated form. Only one
sequence bound significantly in the unmethylated form. Therefore 13
out of 16 predictions are classified as Class III ZREs, 1 is classified as
Class II and 2 did not interact with Zta significantly. Combined with
previously published ZREs, this resulted in a total set of 32 distinct
sequence variants of ZREs (ZRE32) (Table 1).
Identification of ZRE core binding sequences in the EBV
genome
Global analysis of the EBV genome was then undertaken using
an exact pattern match with the 32 validated variants of the ZRE
core sequence (Figure 4). This revealed 469 locations within the
EBV genome that matched one of the ZRE core sequences (Table
S3 and http://bioinf.biochem.sussex.ac.uk/EBV).
Figure 1. Evaluation of predicted ZREs in three EBV promoters. A. Summary of the known (filled box) and predicted (open box) core ZRE
sequences within the proximal 500 nucleotides of the indicated BZLF1, BRLF1 and BMRF1 promoters. The arrows represent the transcription start sites.
Stars represent CpG ZREs. B. Double strand oligonucleotides were generated with the core ZRE sequence and at least 10 nucleotides of cognate
sequence on either side. Following radio labeling, these were incubated with in vitro translated Zta and subject to EMSA. The reactions contained no
protein, 0, control lysate, C or Zta, Z. The DNA probes are indicated above with their originating promoters. C. Double strand oligonucleotides were
generated with the core ZRE sequence and 10 nucleotides of cognate sequence on either side. Following radio labeling, these were subject to in vitro
methylation with SssI methyl transferase (+), or a mock reaction (2). Subsequently, they were incubated with in vitro translated Zta and subject to
EMSA. The reactions contained control lysate, C; or Zta, Z.
doi:10.1371/journal.pone.0025922.g001
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The occurrence of ZREs throughout the EBV genome appears
to be widespread; with 81 out of 86 (94%) EBV promoters
containing at least 1 ZRE core sequence (Table S4). This suggests
that Zta has the potential to regulate the expression of the majority
of EBV genes. Furthermore, 58 EBV promoters contained at least
1 CpG containing ZRE. These regions are methylated during
latency [3,4], suggesting that methylation-dependent Zta interac-
tion with ZREs could influence the expression of a broad range of
EBV genes once Zta is synthesized at the onset of lytic cycle.
Of particular relevance to the control of EBV gene expression
immediately after infection are 22 EBV genes that contained CpG
ZREs but have no methylation independent ZREs in their
promoters (Table 2). These genes are prime contenders to be
regulated in a strictly methylation-dependent manner by Zta.
These were originally classified as displaying early lytic, late lytic
and latent patterns of gene expression [34], but importantly,
genome wide expression studies revealed that all are up regulated
during lytic cycle in BL cells, with the majority reaching peak
levels approximately 24 hours after lytic activation [6].
Three of these promoters were chosen to question whether Zta
interacts with the novel CpG ZREs in vivo; BKRF4, BGLF4 and
BTRF1. The location of the CpG ZREs in each promoter is
indicated in Figure 5. Lytic cycle was activated in Akata cells [35]
by surface immunoglobulin ligation, undertaken in the presence of
acyclovir to inhibit genome replication. Chromatin was subjected
to Zta immunoprecipitation (ChIP) and the interaction of Zta with
these promoters was assessed by Q-PCR. The ability of this
antibody to precipitate Zta bound to chromatin is demonstrated
by western blotting in Figure 6. In addition, we show that Zta as
opposed to a control antibody specifically precipitates chromatin
from a region of oriLyt containing multiple ZREs. Using primer
sets proximal to the CpG ZREs from BKRF4, BGLF4 and BTRF1
compared to primer sets from three regions of the EBV genome
devoid of ZREs, we reveal that Zta specifically binds to all three of
these promoters that contain novel CpG ZREs in vivo (Figure 7).
Discussion
Following several iterations of a predictive and evaluative
approach, we identified a set of 32 distinct sequence variants in the
core 7-nucleotide sequence to which Zta can bind. This includes
20 variants containing a CpG motif, the majority of which (90%)
are only recognized by Zta when they are methylated.
The consensus binding sites identified for non-CpG ZREs are
similar to the binding sites originally described for Zta (Figure 8).
In contrast, the binding sites for CpG containing ZREs are
remarkably different. This sequence is dominated by an almost
invariant G 59 to the absolute prerequisite for me-CpG at positions
19 and 29 in the right-half of the core sequence.
The identification of 58 EBV promoters that harbor methyla-
tion dependent CpG ZREs, combined with the knowledge that the
EBV genome is heavily methylated during latency [3,4], suggests
that Zta plays an important role in overturning epigenetic
silencing of over half of the EBV genes during lytic replication.
Indeed, all three of the promoters tested displayed a strong
interaction with Zta in vivo in ChIP analyses. A genome-wide DNA
binding analysis was recently published identifying sequences to
which a mutant form of Zta, that is replication and transactivation
dead, can interact [3]. This report highlighted the strength of the
interaction between Zta and methylation dependent binding of
Zta to CpG ZREs in the EBV genome.
The EBV genes that contain only methylation-dependent ZREs
are of particular interest. All of these genes are heavily methylated
during viral latency yet unmethylated following replication and
immediately after infection [3,4]. Several are required for EBV
replication and include components of the helicase/primase complex
(BBLF4, BBLF2/BBLF3), the viral protein kinase (BGLF4), and
glycoproteins gL (BKRF2) and gB (BALF4). In addition, the promoters
for BBLF4 and BBLF2/BBLF3 have been validated as being targets
for Zta that are completely dependent on methylation for Zta
activation [3]. Our discovery that one in five EBV promoters contain
CpG ZREs but have no methylation independent ZREs strongly
supports the hypothesis that the unmethylated status of the EBV
genome guards against the expression of the full range of lytic genes
and therefore lytic replication during the establishment of latency.
Zta is the prototypic member of a family of transcription factors
that interact with DNA in a methylation-dependent manner. C/
EBP alpha has recently been shown to share the same
characteristics [36]. It has been suggested that the interaction
between C/EBP alpha and methylated sequence elements are
needed to activate tissue specific genes during differentiation [36].
The biphasic methylation cycle is observed for several different
classes of viruses that establish latency [4]. Yet even KSHV, which
is closely related to EBV, does not contain a functional Zta
homologue. The question arises as to how the methylated genomes
of these viruses can be reactivated. We suggest that the recent
discovery that a cellular transcription factor also has methylation
dependent DNA binding properties [36] implies that other viruses
may rely on host methylation dependent transcription factors to
differentially control the expression of their genomes during the
establishment of latency or replication.
Methods
Computational prediction of ZREs core sequences bound
by Zta
The starting point for the computational approach was the Zta
transcription factor entry T00923 in Transfac 8.3 that includes 6
experimentally verified ZRE binding sites [32,33]. The Promo
algorithm [37,38] generated a position weight matrix (PWM)
Figure 2. Position Frequency Matrix (PFM) of CpG containing
ZREs (PFMCpG5). A. The core seven nucleotide element of the CpG
containing ZREs found within the BRLF1, BRRF1, and BMRF1 (Rp, Nap and
BMRF1p) promoters are shown. B. The number of incidences of each
nucleotide at each position and the thus the frequency were calculated.
C. The consensus sequence is represented as a sequence LOGO.
doi:10.1371/journal.pone.0025922.g002
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based on the T00923 transcription factor entry, and we used it to
search 3 well-characterized Zta-responsive promoters from the
EBV genome (BZLF1 promoter (Zp) 500 bp upstream of the
published transcription start sites were included. A positive match
was taken as one with an 85% similarity rate.
DNA binding assays
Electrophoretic mobility shift assays (EMSA) were undertaken
using Zta protein generated in a wheat germ in vitro translation
system (Promega) and [32P]-radio labeled double strand oligonu-
cleotides, as described previously [39].
Figure 3. Zta recognition and methylation dependence of PFMCpG5 predicted CpG containing ZREs. A. Flow diagram illustrating the
information flow from the PFM to the predictions of novel ZREs in the EBV genome and their subsequent evaluation. B. Core heptamer sequences, in
both forward and reverse complement, of PFMCpG5 predicted CpG containing ZREs within the EBV genome. C. PFMCpG5 was used to predict the
potential for further ZREs in the EBV genome. Double strand oligonucleotides were generated. Following radio labeling, these were subject to in vitro
methylation with SssI methyl transferase (+), or a mock reaction (2). Subsequently, they were incubated with in vitro translated Zta and subject to
EMSA. The reactions contained control lysate, C; or Zta, Z.
doi:10.1371/journal.pone.0025922.g003
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Where indicated in the figure, the central CpG motif was
methylated on both cytosine residues during synthesis (Sigma) or
methylated probes were synthesized or methylated in vitro using the
CpG methyltransferase M.sssI (NEB) [23].
Zta protein (B95-8 strain) was in vitro translated using
wheatgerm extract (Promega).
Zp (296): TAAATTTAGGTGTGTCTATGAGGTA-
CA
Zp (2365): ACAGATGGACCTGAGCCACCCGCC
Zp (2662): CCTCTTTGGCTGACACACCTCTC-
GCCC
Rp (2204) & RpZRE2: CATCTTGTCCTGTGA-
TAAAATCGCTCATAAGCTTAGT
Rp (2439 & 2447): ATGACTCGGGTGTGTC-
CTTGTGTGAGGTCTCACCTG
Rp (2114): CACTCATACTTAAGCGATGCT-
GATGCA
BMRF1p (2173): TGGGGGGTGGTGTGCCATA-
CAAGGGAGC
BMRF1p (2248): CCTTGGTGGATGTGCGAGC-
CATAAAGCA
CpG5 A : AAGCGATGGCCGAGCGAT -
GACTCGTGT
CpG5 B: TCCAGATGACTGAGCGCACGGCCT-
CAA
CpG5C: AAAGATCTGGTTGGCGATCCGGTACAC
CpG5 D: TTGGAAAACATTAGCGACATT-
TACCTG
Table 1. List of core ZREs included within ZRE32.
ZRE Core Sequence Class Names
Forward Reverse
TGAGCCA TGGCTCA I Zp ZREIIIA
TGAGCCA TGGCTCA I Rp ZRE1
TGAGCCA TGGCTCA I Zp (2365)
TTAGCAA TTGCTAA I Zp ZREIIIB
TGTGTAA TTACACA I DSL ZRE1
TGAGCAA TTGCTCA I DSL ZRE2
TGAGCAA TTGCTCA I DSL ZRE7
TGAGCAA TTGCTCA I BMRF1ZRE(244)
TGAGCAA TTGCTCA I BMRF1ZRE(2107)
TGTGTCA TGACACA I DSL ZRE3
TGTGTCA TGACACA I DSL ZRE4
TGTGTCA TGACACA I DSL ZRE6
TGTGTCA TGACACA I DHRS9 ZRE1
TGTGCAA TTGCACA I DSL ZRE5
TGTGCAA TTGCACA I CIITA (221)
TGAGTCA TGACTCA I BSLF2+BMLF1
TGAGTCA TGACTCA I BMRF1 AP-1
TGAGTCA TGACTCA I IL8 AP1
TGAGTCA TGACTCA I DHRS9 (ZRE2)
TGACTAA TTAGTCA I Fp AP-1-Like Site
TGTGTCT AGACACA I Zp (296)
TGGCACA TGTGCCA I BMRF1 (2173)
TGAGTAA TTACTCA I CIITA
TGAGTAA TTACTCA I IL13
GTTGCAA TTGCAAC I IL-8 ZRE
GGAGCGA TCGCTCC III Egr1
TGAGCGA TCGCTCA II Rp ZRE2
TTCGCGA TCGCGAA III Rp ZRE3
TGTGCGA TCGCACA III BMRF1 (2248)
TGAGCGT ACGCTCA III Nap ZRE2
CGGGCGA TCGCCCG III Nap ZRE1
CGAGCGA TCGCTCG III CpG5 A
TGAGCGC GCGCTCA II CpG5 B
TTGGCGA TCGCCAA III CpG5 C
TTAGCGA TCGCTAA III CpG5 D
TGTGCGT ACGCACA III CpG5 E
TTTGCGA TCGCAAA III CpG5 F
TCAGCGA TCGCTGA III CpG5 G
CGTGCGA TCGCACG III CpG5 I
TGCGCGA TCGCGCA III CpG5 J
CGCGCGA TCGCGCG III CpG5 K
AGAGCGA TCGCTCT III CpG5 L
TGGGCGA TCGCCCA III CpG5 M
TAAGCGA TCGCTTA III CpG5 O
TGAGCGG CCGCTCA III CpG5 P
doi:10.1371/journal.pone.0025922.t001
Figure 4. Information flow for the identification of ZREs in the
EBV genome. Flow diagram illustrating the use of the pattern
matching tool (ZRE32) to identify exact sequence matches for the 32
verified ZREs in the EBV genome.
doi:10.1371/journal.pone.0025922.g004
Methylation-Dependent Protein Transcription Factor
PLoS ONE | www.plosone.org 5 October 2011 | Volume 6 | Issue 10 | e25922
Table 2. EBV genes that contain CpG ZREs but have no methylation independent ZREs in their regulatory regions, with the
kinetics and extent of any change in their expression in Akata cells undergoing lytic cycle [6].
Cycle Promoter/Gene Class Sequence
Offset From
Gene Start
Peak
expression
time (hr)
fold change
expression
early lytic BALF1 II TCGCTCA 274 12 8.2
II TCGCTCA 2138
III TCGCCCA 2383
III ACGCTCA 2416
late lytic BALF4 III TCGCGCA 2164 24 15.2
III TCGCTCG 2254
III ACGCACA 2414
unknown BARF0 III CGAGCGA 45 36 7.3
III TGCGCGA 245
early lytic BARF1.2 II TGAGCGA 114 24 9.2
II TGAGCGA 50
III TGGGCGA 2488
early lytic BBLF2/BBLF3 III TCGCCCA 91 12 19.5
early lytic BBLF4 III TCGCTCG 2221 12 7.9
III TCGCACA 2235
III ACGCTCA 2357
late lytic BBRF1 III AGAGCGA 231 24 7
III TTCGCGA 2414
late lytic BBRF3 III TGGGCGA 234 24 20.5
III TTTGCGA 2177
late lytic BDLF1 III TCGCCCG 2390 24 21.5
late lytic BGLF2 II TCGCTCA 133 24 14.3
early lytic BGLF4 II GCGCTCA 2260 8 12.1
III TCGCTTA 2316
late lytic BGRF1/BDRF1 III CGGGCGA 249 24 8.3
late lytic BKRF2 II TGAGCGC 155 24 14.1
III TTAGCGA 185
early lytic BKRF4 III TTAGCGA 270 24 16.3
III TGAGCGG 2246
III CGTGCGA 2302
early lytic BLLF2 III CCGCTCA 218 24 12.4
BOLF1 III TCGCCCG 175 24 4.2
III TCGCTGA 265
late lytic BORF1 III CGGGCGA 130 24 12.4
III TGCGCGA 10
III TGAGCGG 220
early lytic BRRF1 III CGGGCGA 225 24 7
III TGAGCGT 253
late lytic BTRF1 III TGGGCGA 2292 24 8.5
unknown BWRF1 repeats III CGGGCGA 72 , ,
III CGGGCGA 46
III GGAGCGA 2422
latent Cp EBNAs III TGGGCGA 270 24–48 6–8.2
III TTTGCGA 2204
III GGAGCGA 2248
latent Wp EBNAs III TCAGCGA 180 48 6.1
doi:10.1371/journal.pone.0025922.t002
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Figure 5. ZREs in the EBV genome. The entire EBV genome was subjected to an exact pattern match search, using the ZRE32 set of core
sequences. Each site was classed by binding behaviour, and plotted by the first nucleotide of the site to form a genome wide map of ZREs. Class I
sites are indicated by blue diamonds, Class II sites are indicated by red stars, Class III sites are indicated by green triangles, and gene starts and
direction are indicated by arrows. The location of transcription start sites and their orientation are indicated by arrows.
doi:10.1371/journal.pone.0025922.g005
Figure 6. Chromatin precipitation (ChIP) analysis of Zta. Akata cells were induced or not to enter lytic cycle by the addition if anti-IgG as
indicated. 48 hours later the cross-linking agent was added and chromatin and total proteins were harvested. A. The proteins were subject to western
blot analysis for Zta expression. B. A chromatin precipitation experiment was undertaken with the Zta antibody and a control antibody. The
precipitated chromatin and input chromatin were subject to western blot analysis to detect Zta protein. C. The location of ZREs and Q-PCR amplicons
are illustrated for a region central to OriLyt left and for a region flanking OriLyt left. The genome co-ordinates are indicated. Transcription start sites
and the direction of transcription are shown by arrows. Blue diamonds represents the class I ZREs. The amplicons used for Q-PCR are indicated as
black horizontal bars. D. Association of Zta with OriLyt left was assessed using chromatin precipitation from Akata cells in lytic cycle, followed by
Q-PCR. The binding is shown relative to maximal binding to Orilyt left.
doi:10.1371/journal.pone.0025922.g006
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Figure 7. Chromatin precipitation (ChIP) analysis of Zta binding with the EBV genome. A. Five regions of the EBV genome are illustrated,
together with gene names and sequence co-ordinates. Three contain core CpG ZREs and two do not. Transcription start sites and the direction of
transcription are indicated with arrows. Green triangles represent class III CpG ZREs and the red star represents a class II ZRE. The amplicons used for
Q-PCR are indicated as black horizontal bars. F. Association of Zta with the indicated regions of the EBV genome was assessed using chromatin
precipitation from Akata cells in early lytic cycle (stalled prior to DNA replication with acyclovir), followed by Q-PCR. The binding is shown relative to
maximal binding to OriLyt left (OL5).
doi:10.1371/journal.pone.0025922.g007
Methylation-Dependent Protein Transcription Factor
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CpG5 E: TTTGGCGTCATGTGCGTCTGGAT-
GACA
CpG5 F: CAGACTCTGGTTTGCGAGGCTGG-
GCGG
CpG5 G: GCCGCCGCACTCAGCGAGGAG-
GCCTGC
CpG5 H: CGAGGAGGCCTGCGCGTGTTCCT-
CAAC
CpG5 I: CCAATGTCTGCGTGCGAGCCGGG-
CTTG
CpG5 J: CTTTGCGCTCTGCGCGAGGAC-
GAGCTC
CpG5 K: GCAGGGCCCCCGCGCGATCTAGG-
TAGG
CpG5 L: CTCATAGGTCAGAGCGACATA-
GAGGCG
CpG5 M: TTTCAAGTCGTGGGCGAATTAACT-
GAG
CpG5 N: AGCAAGGTGCTGGGCGTGGACC-
GCGCG
CpG5 O: CACTCATACTTAAGCGATGCT-
GATGCA
CpG5 P: GTCATGTAGGTGAGCGGGCAGT-
CCTTG
Chromatin Immunoprecipitation
Chromatin was prepared from Akata cells [35], following
induction with anti IgG, in the presence of 100 mM acyclovir
essentially as described in [40], except that a mixture of Protein
A and protein G were used to capture antibodies. Precipitation
was undertaken using an amino-terminal Zta antibody from
Santa Cruz.
Primers: absolute genomic position and sequence
OL5 F 41195-41216 CAGCTGACCGATGC-
TCGCCA
OL5 R 41342-41323 ATGGTGAGGCAGG-
CAAGGCG
BKRF4 F 98591-98611 CATTGCTCTCT-
GAGCGGTTA
BKRF4 R 98688-98667 ACCAGATGCTTCTTG-
GAGTTG
BGLF4 F 111611-111631 ACCGAGGCTCT-
TAGTTGCTG
BGLF4 R 111686-111666 GTTGCGGACATGGT-
GACTTA
BTRF1 F 126981-127000 AGCTACGCAATCG-
GAGTCA
BTRF1 R 127052-127034 GGAGGCGCAGTCTAG-
CAG
Region with no ZREs
OR1 F 139875-139895 CCGCATGTCCAACCAC-
CACG
OR1 R 139997-139976 ATGCTACCTAGGCCTG-
CGTCC
OL1 F 38229-38249 GCGCAACAGTGCCAC-
CAACC
OL1 R 38302-38282 CAGGACCTGGCGGTAGTG-
CAG
MID-BORF1 F 60768 -60788 TGCCTGA-
GACCTCTCGGACGG
MID-BORF1 R 60817-60792 CCACGACG-
CAGTCCTTAGGATCATG
Generation and application of ZRE PFMs
A position frequency matrix (PFMCpG5) was created using 5
CpG containing ZRE core binding sequences (Figure 3) and
used to search (a) the 3 EBV promoters using the algorithm
Matscan [41], and (b) the complete Human herpesvirus 4
(Epstein-Barr virus) Genome NC_007605 extracted from
GenBank [42]. An 85% similarity score was used to define a
positive match to the PFMCpG5. PFMs for non-CpG ZREs and
CpG ZREs were generated in a similar manner and displayed
using WEBLOGO [43].
Exact pattern matching was employed to search for each of the
32 core ZRE sequences within the EBV genome. A rolling
window of seven nucleotides was used and an exact comparison
of each of the core ZREs sequences, was made. In addition, the
reverse complement of the sequence was checked in the same
manner.
A MySQL database of the locations of the exact matches
within the EBV genome was generated and simple analyses
can be conducted using a web interface which is publically
available at URL: http://bioinf.biochem.sussex.ac.uk/EBV/.
The database uses gene annotations extracted from the
RefSeq NC_007605 entry and data from the exact match
predictions.
Figure 8. Sequence Logos CpG and non-CpG ZREs. The
sequences comprising ZRE32, were divided into those sites which do
not contain a CpG motif, class I ZREs and those that do, class II and class
III ZREs. A. A PFM was created from (PFMnon-CpG ZREs) and is displayed
using relative letter height. B. A PFM was created from (PFMCpG ZREs)
and is displayed using relative letter height.
doi:10.1371/journal.pone.0025922.g008
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Supporting Information
Table S1 The sequences of published ZREs used in this study
are shown, together with their names and references. CpG motifs
are shown in bold.
(DOCX)
Table S2 ZREs predicted using PROMO, together with the
results of their evaluation by DNA binding assays (EMSA) are
shown. CpG motifs are shown in bold.
(DOCX)
Table S3 All ZREs in the EBV genome are shown with the
position of the central nucleotide using RefSeq NC_007605.
(DOCX)
Table S4 The number of ZREs close to each EBV promoter
(between 21000 and +200 from the annotated gene start) are
shown using RefSeq NC_007605.
(DOCX)
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